Mobilising patients with severe acquired brain injury in intensive care (MAWERIC) – Protocol for a randomised cross-over trial

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Mobilising patients with severe acquired brain injury in intensive care (MAWERIC) – Protocol for a randomised cross-over trial. / Riberholt, Christian Gunge; Olsen, Markus Harboe; Berg, Ronan M.G.; Møller, Kirsten.

In: Contemporary Clinical Trials, Vol. 116, 106738, 2022.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Riberholt, CG, Olsen, MH, Berg, RMG & Møller, K 2022, 'Mobilising patients with severe acquired brain injury in intensive care (MAWERIC) – Protocol for a randomised cross-over trial', Contemporary Clinical Trials, vol. 116, 106738. https://doi.org/10.1016/j.cct.2022.106738

APA

Riberholt, C. G., Olsen, M. H., Berg, R. M. G., & Møller, K. (2022). Mobilising patients with severe acquired brain injury in intensive care (MAWERIC) – Protocol for a randomised cross-over trial. Contemporary Clinical Trials, 116, [106738]. https://doi.org/10.1016/j.cct.2022.106738

Vancouver

Riberholt CG, Olsen MH, Berg RMG, Møller K. Mobilising patients with severe acquired brain injury in intensive care (MAWERIC) – Protocol for a randomised cross-over trial. Contemporary Clinical Trials. 2022;116. 106738. https://doi.org/10.1016/j.cct.2022.106738

Author

Riberholt, Christian Gunge ; Olsen, Markus Harboe ; Berg, Ronan M.G. ; Møller, Kirsten. / Mobilising patients with severe acquired brain injury in intensive care (MAWERIC) – Protocol for a randomised cross-over trial. In: Contemporary Clinical Trials. 2022 ; Vol. 116.

Bibtex

@article{bf434d52ab1a4ebfa1e30ecf59336e35,
title = "Mobilising patients with severe acquired brain injury in intensive care (MAWERIC) – Protocol for a randomised cross-over trial",
abstract = "Introduction: In the early phase after severe brain injury, patients are often bedridden in an attempt to control intracranial homeostasis; however, prolonged immobilisation may trigger complications. There is limited knowledge about the physiological effects of mobilisation in this early phase. Objective: To investigate changes in brain tissue oxygen tension when patients are mobilised using a Sara Combilizer{\textregistered} in the early phase after severe brain injury, in a randomised cross-over design. Methods: Patients with traumatic brain injury, subarachnoid haemorrhage or intracranial haematoma, will be randomised to early mobilisation or rest (no mobilisation = control) on the first day that the patient is deemed to be fit for mobilisation, and the opposite on the next day. On both days, patients will undergo continuous multimodal monitoring measuring brain tissue oxygen tension (primary outcome), invasive blood pressure, heart rate, middle cerebral artery blood flow velocity by transcranial Doppler ultrasound, intracranial pressure, and microdialysis markers of cerebral oxidative metabolism. Discussion: Intensive care unit patients with acute brain injury are frequently immobilised in the early phase after the ictus. The optimal timing and intensity of mobilisation is unknown. The present study attempts to establish if early mobilisation is safe with respect to intracranial homeostasis. Protocol version 1.1. Date: 19.02.2022. Ethical registration: H-21002728; approved on August 11, 2021. GDPR registration: P-2021 − 105; approved on February 10, 2021. ClinicalTrials.govidentifier:NCT05038930; approved on September 8, 2021. Electronic case report file: REDCap-database; created on August 13, 2021.",
keywords = "Brain injury, Cerebral autoregulation, Early exercise, Research protocol",
author = "Riberholt, {Christian Gunge} and Olsen, {Markus Harboe} and Berg, {Ronan M.G.} and Kirsten M{\o}ller",
note = "Publisher Copyright: {\textcopyright} 2022 The Authors",
year = "2022",
doi = "10.1016/j.cct.2022.106738",
language = "English",
volume = "116",
journal = "Contemporary Clinical Trials",
issn = "1551-7144",
publisher = "Elsevier",

}

RIS

TY - JOUR

T1 - Mobilising patients with severe acquired brain injury in intensive care (MAWERIC) – Protocol for a randomised cross-over trial

AU - Riberholt, Christian Gunge

AU - Olsen, Markus Harboe

AU - Berg, Ronan M.G.

AU - Møller, Kirsten

N1 - Publisher Copyright: © 2022 The Authors

PY - 2022

Y1 - 2022

N2 - Introduction: In the early phase after severe brain injury, patients are often bedridden in an attempt to control intracranial homeostasis; however, prolonged immobilisation may trigger complications. There is limited knowledge about the physiological effects of mobilisation in this early phase. Objective: To investigate changes in brain tissue oxygen tension when patients are mobilised using a Sara Combilizer® in the early phase after severe brain injury, in a randomised cross-over design. Methods: Patients with traumatic brain injury, subarachnoid haemorrhage or intracranial haematoma, will be randomised to early mobilisation or rest (no mobilisation = control) on the first day that the patient is deemed to be fit for mobilisation, and the opposite on the next day. On both days, patients will undergo continuous multimodal monitoring measuring brain tissue oxygen tension (primary outcome), invasive blood pressure, heart rate, middle cerebral artery blood flow velocity by transcranial Doppler ultrasound, intracranial pressure, and microdialysis markers of cerebral oxidative metabolism. Discussion: Intensive care unit patients with acute brain injury are frequently immobilised in the early phase after the ictus. The optimal timing and intensity of mobilisation is unknown. The present study attempts to establish if early mobilisation is safe with respect to intracranial homeostasis. Protocol version 1.1. Date: 19.02.2022. Ethical registration: H-21002728; approved on August 11, 2021. GDPR registration: P-2021 − 105; approved on February 10, 2021. ClinicalTrials.govidentifier:NCT05038930; approved on September 8, 2021. Electronic case report file: REDCap-database; created on August 13, 2021.

AB - Introduction: In the early phase after severe brain injury, patients are often bedridden in an attempt to control intracranial homeostasis; however, prolonged immobilisation may trigger complications. There is limited knowledge about the physiological effects of mobilisation in this early phase. Objective: To investigate changes in brain tissue oxygen tension when patients are mobilised using a Sara Combilizer® in the early phase after severe brain injury, in a randomised cross-over design. Methods: Patients with traumatic brain injury, subarachnoid haemorrhage or intracranial haematoma, will be randomised to early mobilisation or rest (no mobilisation = control) on the first day that the patient is deemed to be fit for mobilisation, and the opposite on the next day. On both days, patients will undergo continuous multimodal monitoring measuring brain tissue oxygen tension (primary outcome), invasive blood pressure, heart rate, middle cerebral artery blood flow velocity by transcranial Doppler ultrasound, intracranial pressure, and microdialysis markers of cerebral oxidative metabolism. Discussion: Intensive care unit patients with acute brain injury are frequently immobilised in the early phase after the ictus. The optimal timing and intensity of mobilisation is unknown. The present study attempts to establish if early mobilisation is safe with respect to intracranial homeostasis. Protocol version 1.1. Date: 19.02.2022. Ethical registration: H-21002728; approved on August 11, 2021. GDPR registration: P-2021 − 105; approved on February 10, 2021. ClinicalTrials.govidentifier:NCT05038930; approved on September 8, 2021. Electronic case report file: REDCap-database; created on August 13, 2021.

KW - Brain injury

KW - Cerebral autoregulation

KW - Early exercise

KW - Research protocol

U2 - 10.1016/j.cct.2022.106738

DO - 10.1016/j.cct.2022.106738

M3 - Journal article

C2 - 35331944

AN - SCOPUS:85126999826

VL - 116

JO - Contemporary Clinical Trials

JF - Contemporary Clinical Trials

SN - 1551-7144

M1 - 106738

ER -

ID: 308363471